Recent genetic findings in schizophrenia and their therapeutic relevance
about
Systems psychopharmacology: A network approach to developing novel therapiesHippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric DiseaseMolecular neurobiological clues to the pathogenesis of bipolar disorderGene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse ModelsUnderstanding the genetic architectonics of complex CNS traits: Lost by the association, but found in the interaction?Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.Ketamine and phencyclidine: the good, the bad and the unexpected.DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorderInnovative approaches to bipolar disorder and its treatmentMetabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.Translational psychiatry--light at the end of the tunnel.A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.The impact of genetics on future drug discovery in schizophrenia.Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Common variants on 17q25 and gene-gene interactions conferring risk of schizophrenia in Han Chinese population and regulating gene expressions in human brain.Effects of Immune Activation during Early or Late Gestation on N-Methyl-d-Aspartate Receptor Measures in Adult Rat Offspring.Associations between SNPs and immune-related circulating proteins in schizophrenia.A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding.Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance.Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.The Emerging Neurobiology of Bipolar Disorder.Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study.Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges.Structural Analysis of G1691S Variant in the Human Filamin B Gene Responsible for Larsen Syndrome: A Comparative Computational Approach.Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.Genetic correlates of the development of theta event related oscillations in adolescents and young adults.Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis.Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation.Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders
P2860
Q26750901-42F36813-DC7C-4FEA-A5A8-ACAD290BB813Q26767711-FC1859E6-A145-4A74-A608-F56CF9B09769Q26799513-82FCF4BD-E8F9-419D-9B0C-273E07F21C91Q28067507-EA3BCF9A-A6A6-48C8-ACED-155BA9C2D17CQ30279049-1BDC268B-7870-40ED-BB9D-481D39B15877Q30367009-2B9DC30E-96C6-4ABA-A050-BDF2BF7EC079Q30368373-9C0F1760-84D2-489F-A9C3-985E0C18A411Q30827406-FB287F7B-D8FB-48F5-8CAC-49D987A56CBFQ34480719-40431090-87E5-4877-8270-DE80A0E1C35DQ36485741-66C1D9B5-840C-43A8-AA8C-5514BF684F00Q36851161-EDBB008F-7062-40F0-87A7-EB85F689D966Q37486473-29D9E858-961E-4CDB-B428-A8100C23318AQ38370696-7C3574F2-95C8-42F5-9A58-CE131E8FDF26Q38603544-7C934FA8-3C2C-477C-907D-E6EEB65A4031Q38682213-F40E5896-6E88-4966-8D4B-8DE1090BF8D8Q38699013-B0F59090-2BC8-4EAE-B75E-1268C79281DBQ38718345-48EDF89D-824B-4ABE-B839-99CDA2A7AFC1Q38743021-ACA814F7-AE5D-4D93-8CBF-432F0037371BQ39682696-AA913069-1B97-4829-A26A-15C4600178A5Q40147944-325A55AB-0C78-41A8-8BC2-9CF423D58B4DQ41471608-3E055D2D-6F0E-49A0-B53C-328192005AB7Q42002123-9F7D4B32-96D6-42CC-A7C9-CE8B7C771266Q47138421-F913BE9A-9895-4989-968B-F77CA8D395FEQ47583502-266DD2DA-D71A-4D4D-BC62-CF384230520EQ47623099-AF8E79BF-9934-47B2-A170-B3F2A6B0EB86Q47659463-F789D4FF-9905-45B8-9F27-BA129080FA15Q47698386-1B063B66-7ECE-4D4D-8303-8FCFD425909FQ47853545-21403A86-3DA8-46FC-B4BA-CF1233E93A5BQ47870167-6FF4611D-7833-466F-8802-436B7209AED2Q48290136-98192971-E495-4B9C-BB9E-32166E49D577Q48520616-27AB07E5-159C-41C3-B99D-B53E4A836221Q49829601-CE8C35C8-49BF-4CF6-B53A-D102499DC2A0Q50000332-DABF3F34-AC5E-4A60-AE1F-01E71CDB8BF4Q50132400-928559BF-0445-4681-888D-75623382A9AEQ50476959-1B96D8F1-0A75-49C8-9E1D-142B569F6C29Q50568808-3C30D530-E6A4-4D11-920F-186DA1C3573EQ52429670-827A6B67-0E8B-437A-8DC8-10BF8F3DE390Q55453560-B07FE350-9446-449B-826E-53CCCC0D38E3Q55689402-77D0FCF2-C69C-4365-8C62-9851F6C43DB9Q57403235-E7914C9D-2D0C-4A6A-80F3-A3747EF14D7E
P2860
Recent genetic findings in schizophrenia and their therapeutic relevance
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Recent genetic findings in schizophrenia and their therapeutic relevance
@en
type
label
Recent genetic findings in schizophrenia and their therapeutic relevance
@en
prefLabel
Recent genetic findings in schizophrenia and their therapeutic relevance
@en
P2860
P356
P1476
Recent genetic findings in schizophrenia and their therapeutic relevance
@en
P2093
Paul J Harrison
P2860
P356
10.1177/0269881114553647
P407
P577
2014-10-14T00:00:00Z